logo

Neurology Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Neurology Devices Market is segmented by Type of Device (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device, and Other Type of Devices) and Geography.

Home Industry Reports Healthcare Neurology Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 ...

Market Snapshot

neurology devices market
Study Period:

2018 - 2026

Base Year:

2020

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

8.41 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The key factors propelling the growth of the market are the increasing incidence of neurological disorders, huge investments by private players in neurology devices, an increase in R&D in the field of neurotherapy, and rising aging population.

  • The growth of the neurology devices market is attributed to the increasing incidence of neurological disorders that include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson’s disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumor, and stroke.
  • The increasing healthcare spending, increasing foreign direct investment by global medical device manufacturers, and increasing neurological disease prevalence are expected to drive the overall market growth.

Scope of the Report

As per the scope of the report, neurological devices are medical devices that help diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson’s disease, major depression, and traumatic brain injury. The growth of neurological devices is being driven through an emphasis on developing superior neuromodulation and neurostimulation techniques, leveraging minimally invasive procedures that benefit patients. This has resulted in companies investing more in R&D, in an effort to better treat and rehabilitate the brain.

By Type of Device
Cerebrospinal Fluid Management Devices
Interventional Neurology Devices
Interventional/Surgical Simulators
Neurothrombectomy Devices
Carotid Artery Stents
Embolic Coils
Support Devices
Neurosurgery Devices
Neuroendoscopes
Stereotactic Systems
Aneurysm Clips
Other Neurosurgery Devices
Neurostimulation Devices
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Other Neurostimulation Devices
Other Types of Devices
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Sacral Nerve Stimulation Devices Segment is Expected to Grow Fastest during the Forecast Period

The sacral nerve stimulation devices are mostly used for patients for whom drug therapy or other types of medications are not successful. It is performed with the help of a small device, which is capable of sending electrical impulses to the targeted sacral nerves located in the lower back region. These devices are found to be successful in treating bladder problems. Hence, with increasing incidences of overactive bladder, the sacral nerve stimulation devices segment is expected to grow during the forecast period.

The deep brain stimulation devices are also being used to perform deep brain stimulation procedures, by implanting a medical device that is capable of sending electrical impulses to specific target areas in the brain. These devices are generally used to treat neuropsychiatric disorders and are effectively used in treating various other neurological disorders, like Parkinson's disease, essential tremor, dystonia, chronic pain, major depression, and obsessive-compulsive disorder.

Number of alzheimers-dementia cases-2018.png

To understand key trends, Download Sample Report

Asia-Pacific Registered the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period

The Asia-Pacific region is expected to grow, due to the presence of high unmet medical needs, coupled with rapidly rising healthcare R&D investments and growing medical expenditures in emerging economies, such as India and China. There are also a number of government initiatives that are expected to increase over the forecast period.

Moreover, the United States is expected to have the major share in the market, due to factors such as the number of people with neurological conditions is expected to grow sharply over the forecast period, due to improved survival rates, the betterment of general healthcare and infection control, increased longevity, and improved diagnostic techniques. According to a report published by the Alzheimer’s Association, it was estimated that around 5.7 million people in the United States were affected by Alzheimer’s disease (AD) in 2018, which was a drastic increase when compared to the 2016 statistics, where 476,000 people were identified with Alzheimer’s disease.

Neurology Devices Market-geo

To understand geography trends, Download Sample Report

Competitive Landscape

There are market participants involved in R&D for the development of advanced stimulation and neuromodulation techniques with minimally invasive procedures that are more preferable to the patients. Furthermore, many private companies are showing great interest in developing novel neurological devices to earn huge profits. In the coming years, few other players are expected to enter the market.

Neurology Devices-4.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Incidence of Neurological Disorders

      2. 4.2.2 Huge Investments by Private Players in Neurology Devices

      3. 4.2.3 Increase in R&D in the Field of Neurotherapies

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Equipment

      2. 4.3.2 Stringent FDA Validation and Guidelines for New Devices

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Device

      1. 5.1.1 Cerebrospinal Fluid Management Devices

      2. 5.1.2 Interventional Neurology Devices

        1. 5.1.2.1 Interventional/Surgical Simulators

        2. 5.1.2.2 Neurothrombectomy Devices

        3. 5.1.2.3 Carotid Artery Stents

        4. 5.1.2.4 Embolic Coils

        5. 5.1.2.5 Support Devices

      3. 5.1.3 Neurosurgery Devices

        1. 5.1.3.1 Neuroendoscopes

        2. 5.1.3.2 Stereotactic Systems

        3. 5.1.3.3 Aneurysm Clips

        4. 5.1.3.4 Other Neurosurgery Devices

      4. 5.1.4 Neurostimulation Devices

        1. 5.1.4.1 Spinal Cord Stimulation Devices

        2. 5.1.4.2 Deep Brain Stimulation Devices

        3. 5.1.4.3 Sacral Nerve Stimulation Devices

        4. 5.1.4.4 Other Neurostimulation Devices

      5. 5.1.5 Other Types of Devices

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle-East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 B. Braun Melsungen AG

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Stryker Corporation

      4. 6.1.4 Medtronic PLC

      5. 6.1.5 Abbott Laboratories

      6. 6.1.6 Johnson and Johnson

      7. 6.1.7 Smith & Nephew

      8. 6.1.8 MicroPort Scientific Corporation

      9. 6.1.9 Nihon Kohden Corporation

      10. 6.1.10 Penumbra Inc.

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Neurology Devices Market market is studied from 2018 - 2026.

The Neurology Devices Market is growing at a CAGR of 8.41% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Stryker Corporation
  • Medtronic PLC
  • Abbott Laboratories

Are the major companies operating in Neurology Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!